{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T22:11:42Z","timestamp":1770415902528,"version":"3.49.0"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,3,15]],"date-time":"2019-03-15T00:00:00Z","timestamp":1552608000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"DOI":"10.3389\/fneur.2019.00225","type":"journal-article","created":{"date-parts":[[2019,3,15]],"date-time":"2019-03-15T04:38:57Z","timestamp":1552624737000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Clinical Characteristics of Intravenous Injection of Monosialotetrahexosyl Ganglioside Sodium-Related Guillain-Barre Syndrome"],"prefix":"10.3389","volume":"10","author":[{"given":"Miao","family":"Shi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2019,3,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.mayocp.2016.12.002","article-title":"Guillain-Barr\u00e9 Syndrome","volume":"92","author":"Wijdicks","year":"2017","journal-title":"Mayo Clin Proc."},{"key":"B2","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1586\/1744666X.2013.811119","article-title":"Infectious and noninfectious triggers in Guillain-Barre syndrome","volume":"9","author":"Wakerley","year":"2013","journal-title":"Expert Rev Clin Immunol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1136\/jnnp-2011-300309","article-title":"Antiganglioside antibodies are associated with axonal Guillain-Barr\u00e9 syndrome: a Japanese-Italian collaborative study","volume":"83","author":"Sekiguchi","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1111\/j.1468-1331.2012.03730.x","article-title":"Increased incidence of Guillain-Barre syndrome after surgery","volume":"19","author":"Gensicke","year":"2012","journal-title":"Eur J Neurol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.wneu.2015.03.036","article-title":"Acute onset of Guillain-Barr\u00e9 syndrome after elective spinal surgery","volume":"84","author":"Boghani","year":"2015","journal-title":"World Neurosurg"},{"key":"B6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jneuroim.2016.02.003","article-title":"A retrospective analysis of possible triggers of Guillain-Barre syndrome","volume":"293","author":"Yang","year":"2016","journal-title":"J Neuroimmunol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/nrneurol.2014.138","article-title":"Guillain-Barr\u00e9 and Miller Fisher syndromes \u2013new diagnostic classification","volume":"210","author":"Wakerley","year":"2014","journal-title":"Nat Rev Neurol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1159\/000052111","article-title":"Diagnostic and classification criteria for the Guillain-Barr\u00e9 syndrome","volume":"45","author":"Van der Mech\u00e9","year":"2001","journal-title":"Eur Neurol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.1093\/brain\/aww247","article-title":"Guillain-Barr\u00e9 syndrome in the 100 years since its description by Guillain, Barr\u00e9 and Strohl","volume":"139","author":"Hughes","year":"2016","journal-title":"Brain"},{"key":"B10","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/S0140-6736(16)00339-1","article-title":"Guillain-Barr\u00e9 syndrome","volume":"388","author":"Willison","year":"2016","journal-title":"Lancet"},{"key":"B11","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/S0140-6736(78)92644-2","article-title":"Controlled trial prednisolone in acute polyneuropathy","volume":"312","author":"Hughes","year":"1978","journal-title":"Lancet"},{"key":"B12","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1136\/jnnp.72.5.596","article-title":"Clinimetric evaluation of a new overall disability scale in immune mediated polyneuropathies","volume":"72","author":"Merkies","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B13","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1136\/jnnp-2014-307815","article-title":"Electrophysiological diagnosis of Guillain-Barr\u00e9 syndrome subtype: could a single study suffice?","volume":"86","author":"Rajabally","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B14","doi-asserted-by":"publisher","first-page":"4981","DOI":"10.1007\/s12035-015-9430-9","article-title":"Dissecting the role of anti-ganglioside antibodies in Guillain-Barr\u00e9 syndrome: an animal model approach","volume":"53","author":"Asthana","year":"2016","journal-title":"Mol Neurobiol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.cytogfr.2013.05.005","article-title":"Th1\/Th2\/Th17\/Treg cytokines in Guillain-Barr\u00e9 syndrome and experimental autoimmune neuritis","volume":"24","author":"Zhang","year":"2013","journal-title":"Cytokine Growth Factor Rev"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1016\/S0140-6736(05)67665-9","article-title":"Guillain-Barr\u00e9 syndrome","volume":"366","author":"Hughes","year":"2005","journal-title":"Lancet"},{"key":"B17","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.jocn.2008.08.033","article-title":"Guillain\u2013Barre syndrome: an update","volume":"16","author":"Vucic","year":"2009","journal-title":"J Clin Neurosci"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.1093\/brain\/awq260","article-title":"Conduction block in acute motor axonal neuropathy","volume":"133","author":"Kokubun","year":"2010","journal-title":"Brain"},{"key":"B19","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1136\/jnnp.54.9.768","article-title":"Patterns and severity of conduction abnormalities in Guillain-Barr\u00e9 syndrome","volume":"54","author":"Brown","year":"1991","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B20","doi-asserted-by":"publisher","first-page":"CD000094","DOI":"10.1002\/14651858.CD000094","article-title":"Gangliosides for acute ischaemic stroke","volume":"4","author":"Candelise","year":"","journal-title":"Cochrane Database Syst Rev"},{"key":"B21","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0022-510X(03)00215-6","article-title":"Is there a decrease in Guillain\u2013Barre syndrome incidence after bovine ganglioside withdrawal in Italy? A population-based study in the Local Health District of Ferrara, Italy","volume":"216","author":"Govoni","year":"2003","journal-title":"J Neurol Sci"},{"key":"B22","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/0140-6736(91)91475-A","article-title":"Guillain-Barr\u00e9 syndrome and parenteral gangliosides","volume":"338","author":"Latov","year":"1991","journal-title":"Lancet"},{"key":"B23","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1002\/ana.410380214","article-title":"Acute axonal Guillain-Barr\u00e9 syndrome with IgG antibodies against motor axons following parenteral gangliosides","volume":"38","author":"Illa","year":"1995","journal-title":"Ann Neurol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1016\/j.bbadis.2017.02.007","article-title":"Experimental Guillain-Barre syndrome induced by immunization with gangliosides: Keyhole limpet hemocyanin is required for disease triggering","volume":"1863","author":"Funes","year":"2017","journal-title":"Biochim Biophys Acta"},{"key":"B25","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1002\/ana.1012","article-title":"Animal model of axonal Guillain-Barr\u00e9 syndrome induced by sensitization with GM1 ganglioside","volume":"49","author":"Yuki","year":"2001","journal-title":"Ann Neurol"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2019.00225\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,15]],"date-time":"2019-03-15T04:38:59Z","timestamp":1552624739000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2019.00225\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,15]]},"references-count":25,"alternative-id":["10.3389\/fneur.2019.00225"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2019.00225","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,15]]},"article-number":"225"}}